Society for Male Reproduction and Urology Minisymposium - Detecting and Treating Male Factor Infertility
Time:5:45 pm - 6:15 pm
Location:Room 11 - San Diego Convention Center
Gianpiero D. Palermo, M.D., Ph.D., Weill Cornell Medical College
Needs Assessment and Description
Detecting and treating male factor infertility is a critical part
of a couple’s infertility workup. This live course for healthcare
professionals involved in treatment of male-factor infertility
will discuss the prevalence of male factor among infertile
couples and will delineate the state-of-the-art interventions
for this indication. Current treatment approaches for
azoospermic men will be described along with the newest
information on the different elements of the male gamete
that allow evaluation of its embryo developmental
At the conclusion of this session, participants should be able
- Discuss the extent of male infertility and the current
treatment options for the use of ejaculated and surgicallyretrieved
- Identify the current knowledge on the various
components of the male gamete and their impact on
assisted reproductive technology (ART) treatment.
After participating in this session, in my practice, once the
indications for intra-cytoplasmic sperm injection (ICSI) have
been established for an infertile couple, I will inform the
- The risk to the offspring with in vitro fertilization (IVF)/
ICSI has not been proven to be greater than the risk with
- ICSI is a highly experimental procedure and should only
be used in the “worst-case scenario” since very limited
data is available about offspring health.
- Standard in vitro insemination generates consistently
higher fertilization rates than ICSI with a better chance
of achieving a clinical pregnancy.
- ICSI should only be used for azoospermic men.
- Not applicable to my area of practice.